semaglutide nature Long-term weight loss effects of in obesity without diabetes in the SELECT trial Proteomic changes upon treatment with

A succinct review Science Magazine | 33 comments on LinkedIn

But Lilly is hitting a bigger market

What makes this convergence striking: 23andMe used bottom-up population genetics (GWAS, n=27,885) VincoPath used top-down proteome interaction mapping Both independently point to GLP-1R signal strength as the rate-limiting variable Neither alone is sufficient genotype determines receptor density, proteome determines signaling threshold For the Alzheimer's field specifically: EVOKE enrolled 3,808 patients without genetic or proteomic stratification

Practical checklist (simple, scalable): Protein plan + resistance training from day 1 (protect lean mass) Dietitian touchpoint early for patients with poor appetite/food aversions Consider targeted labs in higher-risk patients (baseline + 36 months): vitamin D, ferritin/iron indices, B12 ( thiamine if vomiting/very low intake), plus others as clinically indicated Treat deficiencies proactivelydont wait for fatigue, hair loss, cramps, neuropathy, or plateau frustration Question for colleagues: Do you have a standard nutrition/lab monitoring protocol for GLP-1 patients or do you individualize completely

Un estudio revel por qu 1 de cada 10 personas no responde a frmacos GLP-1 como Ozempic: unas variantes genticas afectaran su eficacia, especialmente en pacientes con diabetes tipo 2.

Use features like bookmarks, note taking and highlighting while reading Living Your Healthiest Semaglutide Life: A Complete Guide to Nutrition and Mindset While on GLP-1 Medications.